• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估无支架主动脉同种异体移植物治疗人工主动脉瓣心内膜炎的效果。

Evaluation of unstented aortic homografts for the treatment of prosthetic aortic valve endocarditis.

作者信息

Petrou M, Wong K, Albertucci M, Brecker S J, Yacoub M H

机构信息

Harefield Hospital, London, UK.

出版信息

Circulation. 1994 Nov;90(5 Pt 2):II198-204.

PMID:7955252
Abstract

BACKGROUND

Prosthetic aortic valve endocarditis is a serious complication that carries a high morbidity and mortality. Aortic homografts have been used in this setting, but long-term results are not available.

METHODS AND RESULTS

Over a 23-year period, 48 patients presented with infected aortic valve substitutes: 28 homografts, 15 mechanical, and 5 xenografts. Nineteen patients had emergency surgery, and the mean interval between the first and second operation was 5.9 years (range, 1 month to 22 years). In 28 patients, the preoperative New York Heart Association (NYHA) class was III or IV. Active endocarditis was present in 39 patients, and the microorganisms grown were Staphylococcus epidermidis (n = 13), Staphylococcus aureus (n = 6), Streptococcus viridans (n = 6), Streptococcus faecalis (n = 4), Candida albicans (n = 5), and Gram-negative spp (n = 2). Aortic root abscesses were found in 28 (58%) patients, and transesophageal echocardiography was 95% accurate in their localization. All patients received homograft aortic valves, 19 as root replacement and 29 using the freehand technique. There were four (8.3%) early deaths; poor left ventricular function and concomitant procedure were identified as risk factors. At a mean follow-up of 4 years (range, 2 months to 19 years) 95% of the patients were in NYHA class I or II without significant aortic regurgitation. The actuarial survival at 5 years was 97% (confidence limit, 84% to 100%), and freedom from endocarditis at 10 years was 97% (confidence limit, 84% to 100%). Multivariate analysis did not identify risk factors for these late events.

CONCLUSIONS

Homograft aortic valves offer good early and long-term results in patients with infected aortic valve substitutes.

摘要

背景

人工主动脉瓣心内膜炎是一种严重并发症,具有较高的发病率和死亡率。主动脉同种异体移植物已用于此情况,但尚无长期结果。

方法与结果

在23年期间,48例患者出现感染性主动脉瓣置换物:28例同种异体移植物、15例机械瓣膜和5例异种移植物。19例患者接受了急诊手术,首次和第二次手术之间的平均间隔为5.9年(范围1个月至22年)。28例患者术前纽约心脏协会(NYHA)心功能分级为III或IV级。39例患者存在活动性心内膜炎,培养出的微生物为表皮葡萄球菌(n = 13)、金黄色葡萄球菌(n = 6)、草绿色链球菌(n = 6)、粪肠球菌(n = 4)、白色念珠菌(n = 5)和革兰阴性菌(n = 2)。28例(58%)患者发现主动脉根部脓肿,经食管超声心动图对其定位的准确率为95%。所有患者均接受同种异体主动脉瓣,19例作为根部置换,29例采用徒手技术。有4例(8.3%)早期死亡;左心室功能差和同期手术被确定为危险因素。平均随访4年(范围2个月至19年),95%的患者NYHA心功能分级为I或II级,无明显主动脉瓣反流。5年时的精算生存率为97%(置信区间84%至100%),10年时无感染性心内膜炎的发生率为97%(置信区间84%至100%)。多因素分析未确定这些晚期事件的危险因素。

结论

同种异体主动脉瓣在感染性主动脉瓣置换患者中提供了良好的早期和长期结果。

相似文献

1
Evaluation of unstented aortic homografts for the treatment of prosthetic aortic valve endocarditis.评估无支架主动脉同种异体移植物治疗人工主动脉瓣心内膜炎的效果。
Circulation. 1994 Nov;90(5 Pt 2):II198-204.
2
[Surgical correction with homograft in native or prosthetic aortic valve infective endocarditis].[同种异体移植用于天然或人工主动脉瓣感染性心内膜炎的手术矫正]
Ital Heart J Suppl. 2002 Jul;3(7):728-37.
3
The homograft aortic valve: a 29-year, 99.3% follow up of 1,022 valve replacements.同种异体主动脉瓣:1022例瓣膜置换术长达29年、随访率99.3%的随访结果
J Heart Valve Dis. 2001 May;10(3):334-44; discussion 335.
4
Surgical treatment of infective mitral valve endocarditis: predictors of early and late outcome.感染性二尖瓣心内膜炎的外科治疗:早期和晚期预后的预测因素
J Heart Valve Dis. 2000 May;9(3):327-34.
5
Homograft reconstruction of the aortic root for endocarditis with periannular abscess: a 17-year study.人工主动脉瓣环重建治疗感染性心内膜炎合并瓣周脓肿:一项17年的研究。
Eur J Cardiothorac Surg. 2005 Jul;28(1):69-75. doi: 10.1016/j.ejcts.2005.03.017. Epub 2005 Apr 18.
6
Aortic valve endocarditis. Determinants of early survival and late morbidity.主动脉瓣心内膜炎。早期生存及晚期发病的决定因素。
Circulation. 1994 Nov;90(5 Pt 2):II175-82.
7
Surgical results for active endocarditis with prosthetic valve replacement: impact of culture-negative endocarditis on early and late outcomes.人工瓣膜置换治疗活动性心内膜炎的手术结果:血培养阴性的心内膜炎对早期和晚期结局的影响。
Eur J Cardiothorac Surg. 2004 Dec;26(6):1104-11. doi: 10.1016/j.ejcts.2004.08.007.
8
Cryopreserved aortic viable homograft for active aortic endocarditis.用于活动性主动脉心内膜炎的冷冻保存的主动脉活性同种异体移植物。
Ann Thorac Surg. 2005 Mar;79(3):767-71. doi: 10.1016/j.athoracsur.2004.08.013.
9
Valve-related events after aortic root replacement with cryopreserved aortic homografts.使用冷冻保存的主动脉同种异体移植物进行主动脉根部置换术后的瓣膜相关事件。
Ann Thorac Surg. 2005 May;79(5):1491-5. doi: 10.1016/j.athoracsur.2004.11.026.
10
Early outcome after surgery for active native and prosthetic aortic valve endocarditis.活动性天然主动脉瓣和人工主动脉瓣心内膜炎手术后的早期结果。
J Heart Valve Dis. 2008 Sep;17(5):508-24; discussion 525.

引用本文的文献

1
Treatment of prosthetic valve endocarditis complicated by destruction of the aortic annulus.人工瓣膜心内膜炎合并主动脉瓣环破坏的治疗。
Gen Thorac Cardiovasc Surg. 2011 Aug;59(8):553-8. doi: 10.1007/s11748-011-0792-2. Epub 2011 Aug 18.
2
Prosthetic valve endocarditis with extensive aortic root abscess: full aortic root reconstruction with stentless bioprosthesis, xenopericardium and mitral valve replacement.人工瓣膜心内膜炎合并广泛主动脉根部脓肿:采用无支架生物瓣膜、异种心包进行全主动脉根部重建及二尖瓣置换术。
Jpn J Thorac Cardiovasc Surg. 2003 Dec;51(12):681-4. doi: 10.1007/s11748-003-0011-x.
3
Aortic root replacement using a homograft for recurrent valve endocarditis.
使用同种异体移植物进行主动脉根部置换治疗复发性瓣膜性心内膜炎。
Jpn J Thorac Cardiovasc Surg. 2002 Sep;50(9):395-7. doi: 10.1007/BF02913193.